Edition:
India

Dawnrays Pharmaceutical Holdings Ltd (2348.HK)

2348.HK on Hong Kong Stock

4.50HKD
23 May 2018
Change (% chg)

HK$0.08 (+1.81%)
Prev Close
HK$4.42
Open
HK$4.49
Day's High
HK$4.50
Day's Low
HK$4.40
Volume
646,237
Avg. Vol
408,465
52-wk High
HK$5.50
52-wk Low
HK$3.93

Chart for

About

Dawnrays Pharmaceutical (Holdings) Limited is an investment holding company principally engaged in the development, manufacture and sale of non-patented pharmaceutical medicines. The products include intermediate pharmaceutical, bulk medicines and finished drugs. The Company operates its business through two segments. The... (more)
No analyst recommendations are available for .

Overall

Beta: 0.57
Market Cap(Mil.): HK$3,569.36
Shares Outstanding(Mil.): 793.19
Dividend: 0.03
Yield (%): 2.89

Financials

  2348.HK Industry Sector
P/E (TTM): 10.85 30.95 32.75
EPS (TTM): 0.41 -- --
ROI: 17.06 14.84 14.38
ROE: 17.56 16.34 16.07

BRIEF-Dawnrays Pharmaceutical (Holdings) Says Li Tung Ming Resigns As Executive Director​

* LI TUNG MING RESIGNED EXECUTIVE DIRECTOR​ Source text for Eikon: Further company coverage:

23 Feb 2018

BRIEF-Dawnrays Pharmaceutical ‍Appoints Chen Shaojun As Executive Director​

* ‍CHEN SHAOJUN, CEO OF CO, HAS BEEN APPOINTED AS AN EXECUTIVE DIRECTOR​

05 Jan 2018

BRIEF-Dawnrays Pharmaceutical (Holdings) Suzhou Dawnrays To Receive RMB351.2 Mln

* UNIT ENTERED RELOCATION COMPENSATION AGREEMENT WITH CHENGNAN STREET OFFICE​

21 Dec 2017

Earnings vs. Estimates